27421843|t|HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer
27421843|a|Serrated colorectal adenocarcinoma (SAC) is a morphologically distinct subtype of colorectal cancer (CRC), in which increased HIF-1α mRNA expression and HIF-1α protein stabilization are typical features. Here we aimed to further elucidate HIF-1α protein expression in serrated and non-serrated colorectal carcinomas (CRCs) and their precursor lesions and its association with vascular endothelial growth factor (VEGF) and microvascular density (MVD). HIF-1α and VEGF expressions were determined immunohistochemically in 134 serrated polyps (SPs), 104 non-serrated adenomas (NSAs), 81 SACs, and 74 matched conventional adenocarcinomas (CCs) and were correlated with morphology, clinicopathological features, and MVD. In premalignant lesions, both HIF-1α and VEGF were expressed in the vast majority of SPs and NSAs. In CRCs, HIF-1α protein was also present in 77.8 % of SACs, while only 20.3 % of CCs were HIF-1α proficient. MVD was significantly higher in SACs, but the serrated morphology was the only significant predictor of MVD in CRC in multivariate analyses. HIF-1α protein is often stabilized in well-vascularized SACs, suggesting hypoxia - independent stabilization of HIF-1α. Moreover, HIF-1α stabilization did not associate with oncogenic activation of BRAF or KRAS or Von Hippel-Lindau (VHL) mutation. Prevalent HIF-1α expression in SAC and its precursors support the importance of HIF-1α -mediated pathways for the serrated route of colorectal carcinogenesis.
27421843	0	6	HIF-1α	T103	UMLS:C1528322
27421843	7	17	expression	T038	UMLS:C1171362
27421843	78	104	serrated colorectal cancer	T038	UMLS:C3272809
27421843	105	139	Serrated colorectal adenocarcinoma	T038	UMLS:C3272809
27421843	141	144	SAC	T038	UMLS:C3272809
27421843	151	166	morphologically	T082	UMLS:C0543482
27421843	176	183	subtype	T170	UMLS:C0449560
27421843	187	204	colorectal cancer	T038	UMLS:C1527249
27421843	206	209	CRC	T038	UMLS:C1527249
27421843	231	237	HIF-1α	T017	UMLS:C1333897
27421843	238	253	mRNA expression	T038	UMLS:C1515670
27421843	258	272	HIF-1α protein	T103	UMLS:C1528322
27421843	273	286	stabilization	T038	UMLS:C1327386
27421843	344	350	HIF-1α	T103	UMLS:C1528322
27421843	351	369	protein expression	T038	UMLS:C1171362
27421843	373	381	serrated	T038	UMLS:C3272809
27421843	386	420	non-serrated colorectal carcinomas	T038	UMLS:C0009402
27421843	422	426	CRCs	T038	UMLS:C0009402
27421843	438	455	precursor lesions	T033	UMLS:C0221198
27421843	481	515	vascular endothelial growth factor	T103	UMLS:C1256770
27421843	517	521	VEGF	T103	UMLS:C1256770
27421843	556	562	HIF-1α	T103	UMLS:C1528322
27421843	567	571	VEGF	T103	UMLS:C1256770
27421843	572	583	expressions	T038	UMLS:C1171362
27421843	629	644	serrated polyps	T017	UMLS:C3266123
27421843	646	649	SPs	T017	UMLS:C3266123
27421843	656	677	non-serrated adenomas	T038	UMLS:C0001430
27421843	679	683	NSAs	T038	UMLS:C0001430
27421843	689	693	SACs	T038	UMLS:C3272809
27421843	710	738	conventional adenocarcinomas	T038	UMLS:C0007112
27421843	740	743	CCs	T038	UMLS:C0007112
27421843	782	810	clinicopathological features	T091	UMLS:C0030667
27421843	824	844	premalignant lesions	T038	UMLS:C0850639
27421843	851	857	HIF-1α	T103	UMLS:C1528322
27421843	862	866	VEGF	T103	UMLS:C1256770
27421843	872	881	expressed	T038	UMLS:C1171362
27421843	906	909	SPs	T017	UMLS:C3266123
27421843	914	918	NSAs	T038	UMLS:C0001430
27421843	923	927	CRCs	T038	UMLS:C1527249
27421843	929	943	HIF-1α protein	T103	UMLS:C1528322
27421843	974	978	SACs	T038	UMLS:C3272809
27421843	1001	1004	CCs	T038	UMLS:C0007112
27421843	1010	1016	HIF-1α	T103	UMLS:C1528322
27421843	1061	1065	SACs	T038	UMLS:C3272809
27421843	1075	1083	serrated	T017	UMLS:C3266123
27421843	1140	1143	CRC	T038	UMLS:C1527249
27421843	1170	1184	HIF-1α protein	T103	UMLS:C1528322
27421843	1194	1204	stabilized	T058	UMLS:C1293130
27421843	1226	1230	SACs	T038	UMLS:C3272809
27421843	1243	1250	hypoxia	T038	UMLS:C0242184
27421843	1253	1278	independent stabilization	T058	UMLS:C1293130
27421843	1282	1288	HIF-1α	T103	UMLS:C1528322
27421843	1300	1306	HIF-1α	T103	UMLS:C1528322
27421843	1307	1320	stabilization	T038	UMLS:C1327386
27421843	1344	1353	oncogenic	T103	UMLS:C0007090
27421843	1354	1364	activation	T038	UMLS:C0017255
27421843	1368	1372	BRAF	T017	UMLS:C0812241
27421843	1376	1380	KRAS	T017	UMLS:C1537502
27421843	1384	1401	Von Hippel-Lindau	T017	UMLS:C0694897
27421843	1403	1406	VHL	T017	UMLS:C0694897
27421843	1408	1416	mutation	T038	UMLS:C0596611
27421843	1428	1434	HIF-1α	T103	UMLS:C1528322
27421843	1435	1445	expression	T038	UMLS:C1171362
27421843	1449	1452	SAC	T038	UMLS:C3272809
27421843	1498	1504	HIF-1α	T103	UMLS:C1528322
27421843	1515	1523	pathways	T038	UMLS:C1704259
27421843	1532	1575	serrated route of colorectal carcinogenesis	T038	UMLS:C3272809